Boston Trust Walden’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-121,352
| Closed | -$16M | – | 399 |
|
|
2025
Q2 | $16M | Sell |
121,352
-95,313
| -44% | -$12.9M | 0.11% | 182 |
|
|
2025
Q1 | $30.1M | Sell |
216,665
-100,581
| -32% | -$15.6M | 0.22% | 159 |
|
|
2024
Q4 | $49.2M | Sell |
317,246
-9,056
| -3% | -$1.53M | 0.35% | 115 |
|
|
2024
Q3 | $59.5M | Sell |
326,302
-1,228
| -0.4% | -$182K | 0.41% | 93 |
|
|
2024
Q2 | $38.9M | Sell |
327,530
-13,560
| -4% | -$1.43M | 0.29% | 135 |
|
|
2024
Q1 | $36.6M | Buy |
341,090
+75,742
| +29% | +$7.53M | 0.26% | 135 |
|
|
2023
Q4 | $26.5M | Sell |
265,348
-2,146
| -0.8% | -$210K | 0.2% | 150 |
|
|
2023
Q3 | $31.8M | Buy |
267,494
+15,712
| +6% | +$2.34M | 0.27% | 135 |
|
|
2023
Q2 | $44.9M | Buy |
251,782
+7,489
| +3% | +$1.37M | 0.37% | 100 |
|
|
2023
Q1 | $40.3M | Buy |
244,293
+11,200
| +5% | +$1.93M | 0.35% | 106 |
|
|
2022
Q4 | $36.7M | Sell |
233,093
-6,842
| -3% | -$1.04M | 0.32% | 112 |
|
|
2022
Q3 | $36.1M | Buy |
239,935
+8,736
| +4% | +$1.45M | 0.36% | 102 |
|
|
2022
Q2 | $38M | Buy |
231,199
+781
| +0.3% | +$150K | 0.36% | 100 |
|
|
2022
Q1 | $51.3M | Buy |
230,418
+5,083
| +2% | +$1.14M | 0.42% | 85 |
|
|
2021
Q4 | $53.5M | Sell |
225,335
-344
| -0.2% | -$80.4K | 0.43% | 78 |
|
|
2021
Q3 | $52.7M | Buy |
225,679
+86,921
| +63% | +$18.2M | 0.47% | 73 |
|
|
2021
Q2 | $28.6M | Sell |
138,758
-3,908
| -3% | -$804K | 0.25% | 143 |
|
|
2021
Q1 | $29.3M | Buy |
142,666
+17,110
| +14% | +$3.61M | 0.28% | 127 |
|
|
2020
Q4 | $26.9M | Sell |
125,556
-1,850
| -1% | -$359K | 0.29% | 124 |
|
|
2020
Q3 | $23.3M | Buy |
127,406
+44,632
| +54% | +$8.4M | 0.29% | 116 |
|
|
2020
Q2 | $15.3M | Buy |
+82,774
| New | +$16.4M | 0.21% | 156 |
|
|
2015
Q2 | – | Sell |
-193,828
| Closed | -$18.1M | – | 350 |
|
|
2015
Q1 | $18.1M | Sell |
193,828
-33,038
| -15% | -$2.89M | 0.27% | 150 |
|
|
2014
Q4 | $18.6M | Sell |
226,866
-350,238
| -61% | -$26.8M | 0.28% | 142 |
|
|
2014
Q3 | $37M | Sell |
577,104
-9,810
| -2% | -$601K | 0.57% | 58 |
|
|
2014
Q2 | $35.7M | Buy |
586,914
+8,686
| +2% | +$513K | 0.52% | 84 |
|
|
2014
Q1 | $34.6M | Sell |
578,228
-3,318
| -0.6% | -$204K | 0.51% | 86 |
|
|
2013
Q4 | $37M | Sell |
581,546
-40,863
| -7% | -$2.63M | 0.54% | 77 |
|
|
2013
Q3 | $42.3M | Buy |
622,409
+20,552
| +3% | +$1.47M | 0.65% | 53 |
|
|
2013
Q2 | $43.4M | Buy |
+601,857
| New | +$39.8M | 0.7% | 44 |
|
Other funds holding ICUI
Boston Trust Walden's ICUI Position: Q3 2025 in Review
Boston Trust Walden sold out of ICU Medical (ICUI) in Q3 2025, closing a stake of 121,352 shares — an estimated $16M sold.
Boston Trust Walden first reported a position in ICUI in Q2 2013 and held it in 29 quarters. The position peaked at $59.5M in Q3 2024. 270 funds tracked by Wall St. Rank hold ICUI as of Q3 2025.
- Boston Trust Walden reported no remaining ICU Medical position as of Q3 2025 after selling out during the quarter.
- Boston Trust Walden sold 121,352 ICU Medical shares in Q3 2025, an estimated $16M.
- Boston Trust Walden first reported a position in ICU Medical in Q2 2013 and held it in 29 quarters.
- Boston Trust Walden's ICU Medical position peaked at $59.5M in Q3 2024.
- 270 funds tracked by Wall St. Rank held ICU Medical as of Q3 2025.
Based on Boston Trust Walden's 13F filing for Q3 2025, filed 17 Oct 2025.